Punter's Pick : BUY SURYA PHARMA Ltd at 90/- EPS 40/- BOOK VALUE 165/- Target 135/- and 185/-

BUY SURYA PHARMA Ltd 10/- face Value Trading in BSE & NSE at 90/- . Immediate Target 135/- ; Short term Target 185/- . And 255/- for Medium Term.

Good Buy Surya Pharma Lts 10/- face Value Trading at 90/- Risk is very very less because company stock was very Valuable because Book value at 165/ and EPS 40/- for 2008-2009 PE 2.5. Pharma Industry Average PE was 15. If you take 5 PE it will go 200/- minimum. As per PE 10 It will go 400/- any time. Just Buy and hold 1 month with good appreciation at 100% Profit.

Lot of Accumulation is going on in NSE an BSE by Company circle people and opearators Because Company stock has good valuable at 95/-.

Surya Pharma recorded total Revenues of 730 Crores and Net Profit 56 Cr for the year ended March 2009. Equity 14.4 Crores EPS 39.95 and PE 2.5; Book Value 165/- . In this 2009 -2010 year Expansion Income will adding; So For 2009- 2010 projection Revenue 958 Cr and Net Profit 75 Cr. EPS 50/- and PE 2. Company having lot of Expansion Plans in future; Surya pharma is targeting 2000+ cr revenues by 2012. Lot of Future for Surya Pahram; Its Multi bagger stock in Future.

I believe it may capitalize its general reserves and reward with BONUS shares to the share holders in the coming years.

Share Holding:-

The Promoters holding 35%, Corporate bodies hold 37%, and Public only 25% Others 3%.
Book value 165/- for 2008-2009.

Positive Points for this stock for Up moving :

1) Company Circle people and Operators are accumulating at current price. Because Company Stock Good Value at 05/- EPS 40/- PE 2.5 and Book Value at 165/- Equity is very small at 14.4 Cr promoters Holding 35%

2) 10% Dividend Paying Company

3) Coming Years Bonus Expecting Good reserves and Good Book Value.

4) Company having lot of Expansion Plans.

5) For this year Expected Revenue 958 Cr and NetProfti 75 Crores EPS 50/- PE 2. In Pharma Companies Avarage PE was 15. If we take at least 5, It will go minimum 200/-.